Affiliated with McGill University in Montreal, Cancer Research in Sao PauloPrincipal Investigator) ,
Chapter 7: Achievements and limitations of cervical cytology screening, Vaccine, vol.24, issue.3S3S3, pp.63-66, 2006. ,
DOI : 10.1016/j.vaccine.2006.05.113
Overview of the European and North American studies on HPV testing in primary cervical cancer screening, International Journal of Cancer, vol.93, issue.5, pp.1095-101, 2006. ,
DOI : 10.1002/ijc.21955
Liquid Compared With Conventional Cervical Cytology, Obstetrics & Gynecology, vol.111, issue.1, pp.167-77, 2008. ,
DOI : 10.1097/01.AOG.0000296488.85807.b3
Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India, International Journal of Cancer, vol.97, issue.1, pp.153-60, 2008. ,
DOI : 10.1002/ijc.23489
Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses, Vaccine, vol.24, issue.3S3, pp.78-81, 2006. ,
DOI : 10.1016/j.vaccine.2006.05.117
Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer, N Engl J Med, vol.357, issue.16, pp.1579-88, 2007. ,
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study, BMJ, vol.337, issue.oct13 1, 2008. ,
DOI : 10.1136/bmj.a1754
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice, The Lancet Oncology, vol.12, issue.7, pp.663-72, 2011. ,
DOI : 10.1016/S1470-2045(11)70145-0
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial, The Lancet, vol.370, issue.9601, pp.796-802, 2007. ,
DOI : 10.1016/S0140-6736(07)61450-0
Cumulative 5-year diagnoses of CIN2, CIN3 or cervical cancer after concurrent high-risk HPV and cytology testing in a primary screening setting, Int J Cancer, vol.116, issue.1, pp.136-179, 2005. ,
Baseline Cytology, Human Papillomavirus Testing, and Risk for Cervical Neoplasia: A 10-Year Cohort Analysis, JNCI Journal of the National Cancer Institute, vol.95, issue.1, pp.46-52, 2003. ,
DOI : 10.1093/jnci/95.1.46
Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil, Revista Panamericana de Salud P??blica, vol.6, issue.4, pp.223-256, 1999. ,
DOI : 10.1590/S1020-49891999000900001
Persistent Human Papillomavirus Infection as a Predictor of Cervical Intraepithelial Neoplasia, JAMA, vol.286, issue.24, pp.3106-3120, 2001. ,
DOI : 10.1001/jama.286.24.3106
Nonparametric Estimation from Incomplete Observations, Journal of the American Statistical Association, vol.37, issue.282, pp.457-81, 1958. ,
DOI : 10.1214/aoms/1177731566
Regression Models and Life-Tables, J R Stat Soc B, vol.34, issue.2, pp.187-220, 1972. ,
DOI : 10.1007/978-1-4612-4380-9_37
Biopsy Correlates of Abnormal Cervical Cytology Classified Using the Bethesda System, Gynecologic Oncology, vol.82, issue.3, pp.516-538, 2001. ,
DOI : 10.1006/gyno.2001.6323
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests, American Journal of Obstetrics and Gynecology, vol.197, issue.4, pp.346-55, 2006. ,
DOI : 10.1016/j.ajog.2007.07.047
Longitudinal relationship between human papillomavirus infection and the incidence and progression of precursor lesions of cervical neoplasia, 2002. ,
Interobserver Reproducibility of Cervical Cytologic and Histologic Interpretations<SUBTITLE>Realistic Estimates From the ASCUS-LSIL Triage Study</SUBTITLE>, JAMA, vol.285, issue.11, pp.1500-1505, 2001. ,
DOI : 10.1001/jama.285.11.1500
NATURAL HISTORY OF CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS, Obstetrics & Gynecology, vol.92, issue.Supplement, pp.727-762, 1998. ,
DOI : 10.1097/00006250-199810001-00046